| Name | Risevistinel |
|---|
| Description | Risevistinel (NYX-783) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be used to inhibit cognitive impairment associated with neurodegenerative diseases, such as mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, Lewy body disease[1]. |
|---|---|
| Related Catalog | |
| Target |
NMDA receptor[1] |
| References |
| Molecular Formula | C14H23N3O4 |
|---|---|
| Molecular Weight | 297.35 |